Detalhe da pesquisa
1.
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Br J Clin Pharmacol
; 89(3): 1105-1114, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214216